Steering all R&D and quality operations for the company’s genomics-based diagnostic and contract- research programs. Backed by 18 years of translational research experience, he has progressed to senior leadership, commercialising numerous molecular assays while directing a multidisciplinary team. Dr. Chavan is an ISO/IEC 17025 & ISO 15189–certified internal auditor who has led GeneOmbio’s NABL, ISO 9001 and DSIR recognitions while successfully hosting vendor audits for global biopharma majors. His technical repertoire spans assay design (qPCR, RT-LAMP, Sanger sequencing, NGS data analytics), quality-by-design method validation, and large-scale genomics projects in virology, nutrigenomics and precision medicine. Author of multiple peer-reviewed publications and invited conference speaker, he earned his doctorate for developing advanced DNA assays for Hepatitis B virus genome analysis. Dr. Chavan’s passion lies in translating cutting-edge molecular science into robust, clinically impactful solutions for human and veterinary health.

Leading operations at geneOmbio, Dr. Purohit is central to client engagement, research oversight, and the strategic planning that propels the company forward. His responsibilities include the design and implementation of robust business strategies, the definition of key performance indicators and growth targets, and the establishment of policies that nurture geneOmbio's culture and vision. Dr. Purohit fosters strong collaboration across diverse executive functions, including Technical, Marketing, Sales, Finance, HR, and Legal.

Dr. Kedar has more than three decades of experience in clinical pharmacology, pharmacogenomics and Nutrigenomics. He has designed, conducted and overseen 50+ Phase I–IV clinical trials and 100+ bioavailability/bioequivalence studies submitted to global regulators including the US FDA, EMA, MHRA and DCGI. His multidisciplinary expertise spans diabetes, oncology, psychiatry, infectious diseases, sports medicine and gynaecology. Backed by 20-plus peer-reviewed publications and international conference presentations, a sought-after ICH-GCP faculty member, ethics-committee and data safety monitoring board expert, Dr. Joshi is committed to advancing evidence-based therapeutics through rigorous science, ethical clinical research and impactful medical education.

Dr. Sumeet is specialised expertise in hospital infection control and laboratory quality management. Trained as a Hospital Infection Control & Patient-Safety practitioner (Symbiosis School, Pune), he is also a QMS & Internal Auditor for ISO 15189 medical laboratories, having completed the CAHO migration programme to the 2022 standard. Dr Chavan holds multiple professional credentials—including Infection Control Professional (CAHO) and HIC certification (MELAP)—and is an active member of CAHO, the American Society for Microbiology, and the Infection Control Academy of India. His continuing education spans workshops on healthcare-associated infection surveillance, global TB diagnostics, and patient-safety leadership. A keen researcher, he recently presented an oral paper at SYMHEALTH 2024, underscoring his commitment to sustainable, high- quality healthcare systems.